MISMATCH REPAIR DEFICIENCY
Clinical trials for MISMATCH REPAIR DEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new MISMATCH REPAIR DEFICIENCY trials appear
Sign up with your email to follow new studies for MISMATCH REPAIR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to boost cancer immunotherapy
Disease control Recruiting nowThis study is testing a new oral medication called Alintegimod, given alongside the immunotherapy drugs ipilimumab and nivolumab. It aims to see if this combination is safe and can help control advanced cancers that have spread or returned after other treatments. The study will e…
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New approach could help surgeons save organs in tough colon cancer cases
Disease control Recruiting nowThis study is testing whether giving immunotherapy drugs before surgery can help surgeons completely remove advanced colon tumors while preserving nearby organs. It focuses on patients whose cancer has a specific genetic feature that makes it respond poorly to standard chemothera…
Matched conditions: MISMATCH REPAIR DEFICIENCY
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Simple blood test could revolutionize colon cancer screening
Diagnosis Recruiting nowThis study is testing a new blood test to see if it can accurately detect colorectal cancer and precancerous growths called adenomas. It aims to provide a less invasive screening option to help find these conditions earlier. The test will also be evaluated for people with Lynch s…
Matched conditions: MISMATCH REPAIR DEFICIENCY
Sponsor: San Raffaele University • Aim: Diagnosis
Last updated Mar 13, 2026 15:06 UTC
-
AI steps in: can a computer find the right cancer trial for you?
Knowledge-focused Recruiting nowThis study is testing a new artificial intelligence (AI) tool designed to help match people with advanced cancer to suitable clinical trials. It will enroll up to 50,000 patients to see if using this AI system makes it easier for patients to find and join trials. The researchers …
Matched conditions: MISMATCH REPAIR DEFICIENCY
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC